Supernus Pharmaceuticals, Inc. Business Finance Contracts & Agreements

42 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Exhibit 10.1 Credit Line Agreement between UBS Bank USA and Supernus Pharmaceuticals, Inc. dated as of February 8, 2023
Credit Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2023
Purchase and Sale Agreement, dated as of June 9, 2006, by and between the Registrant and Rune HealthCare Limited
Purchase Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
Asset Purchase and Contribution Agreement, dated as of December
Purchase Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2021
Press Release Dated September 25, 2019
Release Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2019
Press Release Dated August 26, 2019
Release Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2019
Press Release Dated July 23, 2019
Release Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2019
Additional Issuer Warrant Transaction, dated March 15, 2018, between JPMorgan Chase Bank, National Association, London Branch and Supernus Pharmaceuticals, Inc
Warrant Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Additional Issuer Warrant Transaction, dated March 15, 2018, between Bank of America, N.A. and Supernus Pharmaceuticals, Inc
Warrant Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Additional Issuer Warrant Transaction, dated March 15, 2018, between Deutsche Bank AG, London Branch and Supernus Pharmaceuticals, Inc
Warrant Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Base Issuer Warrant Transaction, dated March 14, 2018, between JPMorgan Chase Bank, National Association, London Branch and Supernus Pharmaceuticals, Inc
Warrant Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Base Issuer Warrant Transaction, dated March 14, 2018, between Bank of America, N.A. and Supernus Pharmaceuticals, Inc
Warrant Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Base Issuer Warrant Transaction, dated March 14, 2018, between Deutsche Bank AG, London Branch and Supernus Pharmaceuticals, Inc
Warrant Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Indenture, dated as of March 19, 2018, between Supernus Pharmaceuticals, Inc. and Wilmington Trust, National Association, as trustee
Indenture Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2018
Purchase Agreement, dated March 14, 2018, among Supernus Pharmaceuticals, Inc. and Jefferies LLC, J.P. Morgan Securities LLC and Cowen and Company, LLC
Purchase Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
SECURITY AGREEMENT
Security Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2014
FIRST SUPPLEMENTAL INDENTURE
Indenture Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2013
CONFIDENTIAL MATERIALS OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. ASTERISKS DENOTE OMISSIONS. COMMERCIAL SUPPLY AGREEMENT
Exchange Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2013
[] Shares Supernus Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2012
AMENDMENT NO. 2 TO STOCK RESTRICTION AGREEMENT
Stock Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2012
STOCK RESTRICTION AGREEMENT
Stock Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2012
AMENDMENT NO. 2 TO INVESTOR RIGHTS AGREEMENT
Investor Rights Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2012
SUPERNUS PHARMACEUTICALS, INC. 2012 EMPLOYEE STOCK PURCHASE PLAN
Stock Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2012
Supernus Pharmaceuticals, Inc. [ ] Shares Common Stock ($0.001 par value) Underwriting Agreement
Underwriting Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2012
PURCHASE AND SALE AGREEMENT
Purchase Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2012
ASSET PURCHASE AND CONTRIBUTION AGREEMENT dated as of December 22, 2005 among SUPERNUS PHARMACEUTICALS, INC., SHIRE LABORATORIES INC. and SHIRE PLC
Purchase Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2012
UNIT PURCHASE AGREEMENT dated as of December 14, 2011 by and between SUPERNUS PHARMACEUTICALS, INC., and ROYALTY OPPORTUNITIES S.r.I
Purchase Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2012
FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT
Loan Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2012
WARRANT TO PURCHASE STOCK
Warrant Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2012
SECURED PROMISSORY NOTE (Term B Loan)
Loan Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2012
SECURED PROMISSORY NOTE - 2 (Term B Loan)
Loan Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2012
SECURED PROMISSORY NOTE - 1 (Term B Loan)
Loan Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2012
AMENDED AND RESTATED WARRANT TO PURCHASE STOCK
Warrant Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2012
LOAN AND SECURITY AGREEMENT
Loan Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
NY
2011
INDENTURE dated as of April 15, 2008 by and between TCD ROYALTY SUB LLC, a Delaware limited liability company, as issuer of the Notes described herein, and U.S. BANK NATIONAL...
Indenture Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2011
PURCHASE AND SALE AGREEMENT
Purchase Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2011
ASSET PURCHASE AND CONTRIBUTION AGREEMENT dated as of December 22, 2005 among SUPERNUS PHARMACEUTICALS, INC., SHIRE LABORATORIES INC. and SHIRE PLC
Purchase Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2011
WARRANT TO PURCHASE STOCK
Warrant Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
DE
2011
SECURED PROMISSORY NOTE
Note Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2011
SECURED PROMISSORY NOTE
Note Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2011
INVESTOR RIGHTS AGREEMENT
Investor Rights Agreements
Supernus Pharmaceuticals, Inc.
Pharmaceuticals
2010